Seattle Genetics CEO Clay Siegall's 2021 pay rises 15% to $19M
Seattle Genetics reports 2021 executive compensation
By ExecPay News
Published: March 30, 2022
Seattle Genetics reported fiscal year 2021 executive compensation information on March 30, 2022.
In 2021, five executives at Seattle Genetics received on average a compensation package of $8.8M, a 21% increase compared to previous year.
Average pay of disclosed executives at Seattle Genetics
Clay B. Siegall, Chief Executive Officer, received $19M in total, which increased by 15% compared to 2020. 58% of Siegall's compensation, or $11M, was in stock awards. Siegall also received $1.8M in non-equity incentive plan, $4.8M in option awards, $1.1M in salary, as well as $120K in other compensation.
For fiscal year 2021, the median employee pay was $250,158 at Seattle Genetics. Therefore, the ratio of Clay B. Siegall's pay to the median employee pay was 76 to one.
Roger D. Dansey, Chief Medical Officer, received a compensation package of $8.9M, which increased by 25% compared to previous year. 52% of the compensation package, or $4.6M, was in stock awards.
Todd E. Simpson, Chief Financial Officer, earned $6M in 2021, a 30% increase compared to previous year.
Chip R. Romp, Executive Vice President, Commercial U.S, received $5.3M in 2021, which increases by 16% compared to 2020.
Jean I. Liu, Chief Legal Officer, earned $5.1M in 2021, a 31% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 30, 2022.